Back
HFA Premium Access

Cancer therapeutic related cardiac dysfunction among active breast cancer patients: A Cardio-Oncology registry

Session: Poster Session 2 - Chronic Heart Failure – Pathophysiology and Mechanisms
Topic: Cardiotoxicity of Drugs and Other Therapies
Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)
0 follower

46 more presentations in this session

Cardiopulmonary exercise testing in pulmonary hypertension associated with congenital heart disease vs. other forms of pulmonary hypertension: physiological insights

Access
Like
Thumbnail

The occurence of Heart failure result in low weight at birth in woman with congenital heart disease

Speaker: Doctor S. Bele (Tirana, AL)

Access
Abstract
Like
Thumbnail

Relationship between serotonergic-modulating psycoactive treatments and 24-hour Cheyne-Stokes respiration occurrence in systolic heart failure.

Speaker: Doctor G. Mirizzi (Pisa, IT)

Access
Abstract
Like
Thumbnail

The association between markers of fibrosis and myocardial dyssynchrony in patients with CHF

Speaker: Professor O. Bilchenko (Kharkiv, UA)

Access
Abstract
Like
Thumbnail

Circulating biomarkers of inflammation and left ventricular hypertrophy in patients with heart failure with preserved ejection fraction

Speaker: Professor O. Bilchenko (Kharkiv, UA)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Doctor M. Laufer-Perl, Doctor S. Bele, Doctor G. Mirizzi, Professor O. Bilchenko, Professor O. Bilchenko
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources